SOURCE: Universal Detection Technology

March 17, 2008 16:00 ET

Innovative Biosensors, Inc. and Universal Detection Technology Partner on Marketing of Biological Detection and Identification Systems for Environmental Monitoring

Biological Hazard Monitoring Innovators Team to Distribute Systems for Rapid BioThreat Assessment

LOS ANGELES, CA--(Marketwire - March 17, 2008) - Universal Detection Technology ( (OTCBB: UDTT) (FRANKFURT: PO8), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, announced today that it has joined forces with Innovative Biosensors, Inc. to address the market need for bio-threat detectors for clients dependent on accurate, rapid environmental assessments.

Innovative Biosensors, Inc. (IBI) of Rockville, MD, a company developing rapid, ultra-sensitive tests to identify harmful pathogens, and UDTT announced they will team to market and distribute their respective and complementary products to protect people from bioterrorism threats in indoor and outdoor environments.

Under the agreement, both IBI and UDTT will market and distribute their partner's biodection equipment, in addition to their own products, broadening their ability to develop complete solutions for building and other security applications across government, military and commercial markets.

IBI's proprietary BioFlash biological identifier is rugged, portable, and incorporates a high-volume aerosol sampler. The integrated technology provides rapid, specific and sensitive identification of up to 21 biological threat agents in single test or multi-test formats in less than five minutes.

"IBI's BioFlash is the first, fully integrated system which combines the collection and real-time identification functions, to provide rapid and cost effective detection and identification of biological threat agents," said Rick Thomas, Vice President of Business Development for IBI. "IBI's strategic goal is to continue to evolve through the expansion of our current BioFlash technology system along with partners such as UDTT, to provide total issue encompassing solutions for both military and civilian biothreat protection."

UDTT's BSM-2000 is an autonomous air monitoring system capable of detecting abnormal levels of airborne bacterial spores such as anthrax. The BSM-2000 technology has been developed by NASA's Jet Propulsion Laboratory and has been used in NASA's Planetary Protection Program before being modified by UDTT for use in bioterrorism detection. The BSM-2000 combines a bioaerosol capture device with a simple and robust chemical test for bacterial spores that is completely automated.

"We are very excited to join forces with IBI and we look forward to actively co-market our technologies to users in the United States and around the world," said Mr. Jacques Tizabi, UDTT's Chief Executive Officer.

For more information please visit or

Email us at

About Innovative Biosensors, Inc.

Innovative Biosensors, Inc. is a privately held company developing novel technologies for the rapid detection of pathogens in biodefense applications and human clinical diagnostics. IBI's technology has been tailored to rapidly and sensitively detect biological threats in building security, military, and civil defense applications. Additionally, the technology platform is being used to develop rapid tests for the detection of hospital-acquired infections. Additional information is available at Innovative Biosensors, Inc.

About Universal Detection Technology

Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bio-terror 'smoke' detector that detects certain bio hazard substances. For more information, please visit

Forward-Looking Statements

Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.

Contact Information